Doctor's Guide -- MONTREAL -- October 27, 2010 -- There appears to be no association between preoperative angiotensin-converting enzyme (ACE)-inhibitor therapy and adverse in-hospital outcomes or mid-term survival following coronary artery bypass grafting (CABG) surgery, researchers said here at the 2010 Canadian Cardiovascular Congress (CCC).
